Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, Ian Judson et al.|The Lancet|2012Cited by 2.1k
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialPatrick Schöffski, Shreyaskumar Patel, Sant P. Chawla et al.|The Lancet|2016Cited by 766
Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue SarcomasSant P. Chawla, George D. Demetri|Journal of Clinical Oncology|2011Cited by 247
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Vivek Subbiah, Justin F. Gainor et al.|Nature Reviews Clinical Oncology|2021Cited by 140
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Bruce Allen Bach, R. J. Grimer et al.|World Journal of Surgical Oncology|2018Cited by 56